Search Results

There are 7439944 results for: content related to: Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial

  1. You have free access to this content
    Imatinib mesylate treatment of nephrogenic systemic fibrosis

    Arthritis & Rheumatism

    Volume 58, Issue 8, August 2008, Pages: 2543–2548, Jonathan Kay and Whitney A. High

    Version of Record online : 30 JUL 2008, DOI: 10.1002/art.23696

  2. You have free access to this content
    Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents

    International Journal of Urology

    Volume 19, Issue 9, September 2012, Pages: 806–811, Kazuhiro Kitajima, Tetsuo Maeda, Sanae Watanabe, Yoshiko Ueno and Kazuro Sugimura

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1442-2042.2012.03042.x

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 19, Issue 12, 1127, Version of Record online: 26 NOV 2012

  3. Nephrogenic systemic fibrosis and the role of gadolinium contrast media

    Journal of Medical Imaging and Radiation Oncology

    Volume 52, Issue 4, August 2008, Pages: 339–350, AJ Van Der Molen

    Version of Record online : 16 SEP 2008, DOI: 10.1111/j.1440-1673.2008.01965.x

  4. You have free access to this content
    Validation of a Screening Instrument for Nephrogenic Systemic Fibrosis

    Arthritis Care & Research

    Volume 65, Issue 4, April 2013, Pages: 637–642, Xinaida Taligare Lima, Maria Beatrice Alora-Palli, Alexandra Boer Kimball and Jonathan Kay

    Version of Record online : 28 MAR 2013, DOI: 10.1002/acr.21877

  5. Nephrogenic systemic fibrosis: A case report and review on Japanese patients

    The Journal of Dermatology

    Volume 39, Issue 5, May 2012, Pages: 449–453, Yuka MATSUMOTO, Yoshihiko MITSUHASHI, Fumiko MONMA, Masakazu KAWAGUCHI, Tamio SUZUKI, Chie MIYABE, Atsuyuki IGARASHI and Ryoji TSUBOI

    Version of Record online : 31 OCT 2011, DOI: 10.1111/j.1346-8138.2011.01407.x

  6. Gadolinium-Associated Nephrogenic Systemic Fibrosis in a 9-Year-Old Boy

    Pediatric Dermatology

    Volume 26, Issue 5, September/October 2009, Pages: 579–582, Clare Foss, Jeff K. Smith, Luis Ortiz, Coral Hanevold and Loretta Davis

    Version of Record online : 11 MAR 2009, DOI: 10.1111/j.1525-1470.2008.00802.x

  7. Nephrogenic systemic fibrosis in a gadolinium-naïve patient: Successful treatment with oral sirolimus

    Australasian Journal of Dermatology

    Volume 56, Issue 3, August 2015, Pages: e59–e62, Christopher Ross, Nicholas De Rosa, Gillian Marshman and David Astill

    Version of Record online : 21 OCT 2014, DOI: 10.1111/ajd.12176

  8. Sclerotic bodies in nephrogenic systemic fibrosis: a new histopathologic finding

    Journal of Cutaneous Pathology

    Volume 36, Issue 5, May 2009, Pages: 548–552, Jag Bhawan, Brian L. Swick, Amy B. Koff and Mary S. Stone

    Version of Record online : 30 MAR 2009, DOI: 10.1111/j.1600-0560.2008.01111.x

  9. “Carcinoid-Like” Tricuspid Valvulopathy Associated with Nephrogenic Systemic Fibrosis


    Volume 28, Issue 3, March 2011, Pages: E46–E49, S. Michael Gharacholou, Joseph J. Maleszewski, Barry A. Borlaug, Fernando G. Cosio, Joseph A. Dearani, Sudhir S. Kushwaha and Naser M. Ammash

    Version of Record online : 3 MAR 2011, DOI: 10.1111/j.1540-8175.2010.01320.x

  10. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: Three case reports and review of literature

    Journal of Clinical Apheresis

    Volume 23, Issue 4, 2008, Pages: 144–150, Kiran Mathur, Scott Morris, Chris Deighan, Rachel Green and Kenneth William Douglas

    Version of Record online : 16 JUL 2008, DOI: 10.1002/jca.20170

  11. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure

    Journal of Cutaneous Pathology

    Volume 40, Issue 11, November 2013, Pages: 935–944, Susanne G. Schäd, Peter Heitland, W. Nikolaus Kühn-Velten, Gerd E. Gross and Ludwig Jonas

    Version of Record online : 16 SEP 2013, DOI: 10.1111/cup.12214

  12. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000–2006


    Volume 16, Issue 2, February 2011, Pages: 243–248, JAMIE C KENDRICK-JONES, DAVID M VOSS and JANAK R DE ZOYSA

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1440-1797.2010.01397.x

  13. You have free access to this content
    Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide

    British Journal of Pharmacology

    Volume 165, Issue 4b, February 2012, Pages: 1151–1162, N Fretellier, JM Idée, P Bruneval, S Guerret, F Daubiné, G Jestin, C Factor, N Poveda, A Dencausse, F Massicot, O Laprévote, C Mandet, N Bouzian, M Port and C Corot

    Version of Record online : 26 JAN 2012, DOI: 10.1111/j.1476-5381.2011.01585.x

  14. NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Patient Characteristics and Risk Factors for Nephrogenic Systemic Fibrosis Following Gadolinium Exposure

    Seminars in Dialysis

    Volume 21, Issue 2, March/April 2008, Pages: 135–139, Thomas Grobner and Friedrich C. Prischl

    Version of Record online : 23 JAN 2008, DOI: 10.1111/j.1525-139X.2007.00406.x

  15. Gadolinium-Induced Nephrogenic Systemic Fibrosis Is Associated with Insoluble Gd Deposits in Tissues: In Vivo Transmetallation Confirmed by Microanalysis

    Journal of Cutaneous Pathology

    Volume 36, Issue 12, December 2009, Pages: 1244–1254, Charu Thakral and Jerrold L. Abraham

    Version of Record online : 7 JUL 2009, DOI: 10.1111/j.1600-0560.2009.01283.x

  16. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case–control study from Denmark

    British Journal of Dermatology

    Volume 165, Issue 4, October 2011, Pages: 828–836, T.R. Elmholdt, M. Pedersen, B. Jørgensen, K. Søndergaard, J.D. Jensen, M. Ramsing and A.B. Olesen

    Version of Record online : 27 SEP 2011, DOI: 10.1111/j.1365-2133.2011.10465.x

  17. The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange

    Journal of Clinical Apheresis

    Volume 28, Issue 4, August 2013, Pages: 317–320, Jessica L. Poisson, Aaron Low and Yara A. Park

    Version of Record online : 21 FEB 2013, DOI: 10.1002/jca.21253

  18. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents

    Journal of Magnetic Resonance Imaging

    Volume 41, Issue 5, May 2015, Pages: 1259–1267, Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, Sameer M. Mazhar, Irene Cruite, Tanya Wolfson, Sebastian B. Sugay, Gabriella Iussich, Masoud Shiehmorteza, Yuko Kono, Alexander Kuo and Claude B. Sirlin

    Version of Record online : 9 MAY 2014, DOI: 10.1002/jmri.24650

  19. Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia

    Journal of Cutaneous Pathology

    Volume 37, Issue 8, August 2010, Pages: 877–880, Hadas Skupsky, Rachel Abuav, Whitney High, Carolyn Pass and Gary Goldenberg

    Version of Record online : 23 AUG 2009, DOI: 10.1111/j.1600-0560.2009.01398.x

  20. Sclerotic bodies beyond nephrogenic systemic fibrosis

    Journal of Cutaneous Pathology

    Volume 40, Issue 9, September 2013, Pages: 812–817, Jag Bhawan, Tanya A. Perez-Chua and Lynne Goldberg

    Version of Record online : 29 JUN 2013, DOI: 10.1111/cup.12187